Novo Nordisk receives Complete Response Letter in the US
Bagsværd, Denmark, 10 July 2024 – Novo Nordisk today announced that the US Food and Drug Administration (FDA) has issued ...
Read moreBagsværd, Denmark, 10 July 2024 – Novo Nordisk today announced that the US Food and Drug Administration (FDA) has issued ...
Read more100% of patients enrolled achieved a partial response or betterMilder and less frequent drug-related adverse events were observed compared to ...
Read moreTORONTO, May 27, 2024 (GLOBE NEWSWIRE) -- Raising the alarm about the urgent threat to public health care, the Ontario ...
Read more- Beneficial clinical responses observed with EO2463 monotherapy already at 6 weeks and complete response rate of 78% in patients ...
Read moreChitkara University was abuzz with excitement as more than 600 students and alumni gathered for the pre-launch event of ...
Read moreSri Ramakrishna Hospital, a leading healthcare institution in emergency healthcare and disaster response, conducted an emergency awareness event for ...
Read moreST. LOUIS, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Defender Pharmaceuticals, Inc. (the “Company” or “Defender”), a privately held life sciences ...
Read moreData update from AFM24-102 Phase 1/2a combination study includes 15 heavily pre-treated patients from the EGFR-wildtype (wt) non-small cell lung ...
Read more71% intracranial objective response rate (iORR) in BriaCell patients with Central Nervous System (CNS) metastases support clinical efficacy of Bria-IMT™, ...
Read moreCompany announcement – No. 45 / 2023 U.S. Food and Drug Administration issues Complete Response Letter for dasiglucagon in congenital ...
Read more© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.
© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.